ID   STK24_HUMAN             Reviewed;         443 AA.
AC   Q9Y6E0; O14840; Q5JV92;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   12-OCT-2022, entry version 204.
DE   RecName: Full=Serine/threonine-protein kinase 24;
DE            EC=2.7.11.1;
DE   AltName: Full=Mammalian STE20-like protein kinase 3;
DE            Short=MST-3;
DE   AltName: Full=STE20-like kinase MST3;
DE   Contains:
DE     RecName: Full=Serine/threonine-protein kinase 24 36 kDa subunit;
DE     AltName: Full=Mammalian STE20-like protein kinase 3 N-terminal;
DE              Short=MST3/N;
DE   Contains:
DE     RecName: Full=Serine/threonine-protein kinase 24 12 kDa subunit;
DE     AltName: Full=Mammalian STE20-like protein kinase 3 C-terminal;
DE              Short=MST3/C;
GN   Name=STK24; Synonyms=MST3, STK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RX   PubMed=9353338; DOI=10.1074/jbc.272.45.28695;
RA   Schinkmann K., Blenis J.;
RT   "Cloning and characterization of a human STE20-like protein kinase with
RT   unusual cofactor requirements.";
RL   J. Biol. Chem. 272:28695-28703(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), PHOSPHORYLATION AT THR-18,
RP   MUTAGENESIS OF THR-18, AND VARIANT VAL-414.
RC   TISSUE=Brain;
RX   PubMed=10644707; DOI=10.1074/jbc.275.4.2513;
RA   Zhou T.-H., Ling K., Guo J., Zhou H., Wu Y.-L., Jing Q., Ma L., Pei G.;
RT   "Identification of a human brain-specific isoform of mammalian STE20-like
RT   kinase 3 that is regulated by cAMP-dependent protein kinase.";
RL   J. Biol. Chem. 275:2513-2519(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEOLYTIC PROCESSING, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-65 AND
RP   ASP-321.
RX   PubMed=12107159; DOI=10.1074/jbc.m202468200;
RA   Huang C.Y., Wu Y.M., Hsu C.Y., Lee W.S., Lai M.D., Lu T.J., Huang C.L.,
RA   Leu T.H., Shih H.M., Fang H.I., Robinson D.R., Kung H.J., Yuan C.J.;
RT   "Caspase activation of mammalian sterile 20-like kinase 3 (Mst3).";
RL   J. Biol. Chem. 277:34367-34374(2002).
RN   [7]
RP   SUBCELLULAR LOCATION, NUCLEAR LOCALIZATION SIGNAL, AND NUCLEAR EXPORT
RP   SIGNAL.
RX   PubMed=15304321; DOI=10.1016/j.febslet.2004.07.007;
RA   Lee W.S., Hsu C.Y., Wang P.L., Huang C.Y., Chang C.H., Yuan C.J.;
RT   "Identification and characterization of the nuclear import and export
RT   signals of the mammalian Ste20-like protein kinase 3.";
RL   FEBS Lett. 572:41-45(2004).
RN   [8]
RP   COFACTOR, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15917084; DOI=10.1016/j.jinorgbio.2005.03.003;
RA   Lu T.J., Huang C.Y., Yuan C.J., Lee Y.C., Leu T.H., Chang W.C., Lu T.L.,
RA   Jeng W.Y., Lai M.D.;
RT   "Zinc ion acts as a cofactor for serine/threonine kinase MST3 and has a
RT   distinct role in autophosphorylation of MST3.";
RL   J. Inorg. Biochem. 99:1306-1313(2005).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16314523; DOI=10.1128/mcb.25.24.11019-11029.2005;
RA   Stegert M.R., Hergovich A., Tamaskovic R., Bichsel S.J., Hemmings B.A.;
RT   "Regulation of NDR protein kinase by hydrophobic motif phosphorylation
RT   mediated by the mammalian Ste20-like kinase MST3.";
RL   Mol. Cell. Biol. 25:11019-11029(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   FUNCTION, PHOSPHORYLATION AT THR-190, AND MUTAGENESIS OF THR-190.
RX   PubMed=17046825; DOI=10.1074/jbc.m605035200;
RA   Lu T.J., Lai W.Y., Huang C.Y., Hsieh W.J., Yu J.S., Hsieh Y.J., Chang W.T.,
RA   Leu T.H., Chang W.C., Chuang W.J., Tang M.J., Chen T.Y., Lu T.L., Lai M.D.;
RT   "Inhibition of cell migration by autophosphorylated mammalian sterile 20-
RT   like kinase 3 (MST3) involves paxillin and protein-tyrosine phosphatase-
RT   PEST.";
RL   J. Biol. Chem. 281:38405-38417(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4 (ISOFORM A), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   FUNCTION, AND PHOSPHORYLATION AT THR-190.
RX   PubMed=19604147; DOI=10.1042/bsr20090096;
RA   Chen C.B., Ng J.K., Choo P.H., Wu W., Porter A.G.;
RT   "Mammalian sterile 20-like kinase 3 (MST3) mediates oxidative-stress-
RT   induced cell death by modulating JNK activation.";
RL   Biosci. Rep. 29:405-415(2009).
RN   [14]
RP   INTERACTION WITH CTTNBP2NL.
RX   PubMed=18782753; DOI=10.1074/mcp.m800266-mcp200;
RA   Goudreault M., D'Ambrosio L.M., Kean M.J., Mullin M.J., Larsen B.G.,
RA   Sanchez A., Chaudhry S., Chen G.I., Sicheri F., Nesvizhskii A.I.,
RA   Aebersold R., Raught B., Gingras A.C.;
RT   "A PP2A phosphatase high density interaction network identifies a novel
RT   striatin-interacting phosphatase and kinase complex linked to the cerebral
RT   cavernous malformation 3 (CCM3) protein.";
RL   Mol. Cell. Proteomics 8:157-171(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2 (ISOFORM A), PHOSPHORYLATION
RP   [LARGE SCALE ANALYSIS] AT SER-4 (ISOFORM A), CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS] (ISOFORM A), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   FUNCTION.
RX   PubMed=19855390; DOI=10.1038/nn.2414;
RA   Lorber B., Howe M.L., Benowitz L.I., Irwin N.;
RT   "Mst3b, an Ste20-like kinase, regulates axon regeneration in mature CNS and
RT   PNS pathways.";
RL   Nat. Neurosci. 12:1407-1414(2009).
RN   [17]
RP   FUNCTION.
RX   PubMed=19782762; DOI=10.1016/j.biocel.2009.09.012;
RA   Lin C.Y., Wu H.Y., Wang P.L., Yuan C.J.;
RT   "Mammalian Ste20-like protein kinase 3 induces a caspase-independent
RT   apoptotic pathway.";
RL   Int. J. Biochem. Cell Biol. 42:98-105(2010).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2 (ISOFORM A), PHOSPHORYLATION
RP   [LARGE SCALE ANALYSIS] AT SER-4 (ISOFORM A), CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS] (ISOFORM A), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2 (ISOFORM A), PHOSPHORYLATION
RP   [LARGE SCALE ANALYSIS] AT SER-4 (ISOFORM A), CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS] (ISOFORM A), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-190, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH PDCD10 AND RIPOR1.
RX   PubMed=27807006; DOI=10.1242/jcs.198614;
RA   Mardakheh F.K., Self A., Marshall C.J.;
RT   "RHO binding to FAM65A regulates Golgi reorientation during cell
RT   migration.";
RL   J. Cell Sci. 129:4466-4479(2016).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 27-315 IN COMPLEX WITH ADENINE;
RP   ADP AND MANGANESE IONS, SUBUNIT, AND PHOSPHORYLATION AT THR-190.
RX   PubMed=20124694; DOI=10.1107/s0907444909047507;
RA   Ko T.P., Jeng W.Y., Liu C.I., Lai M.D., Wu C.L., Chang W.J., Shr H.L.,
RA   Lu T.J., Wang A.H.;
RT   "Structures of human MST3 kinase in complex with adenine, ADP and Mn2+.";
RL   Acta Crystallogr. D 66:145-154(2010).
RN   [24]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-414 AND ILE-426.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase that acts on both serine and
CC       threonine residues and promotes apoptosis in response to stress stimuli
CC       and caspase activation. Mediates oxidative-stress-induced cell death by
CC       modulating phosphorylation of JNK1-JNK2 (MAPK8 and MAPK9), p38 (MAPK11,
CC       MAPK12, MAPK13 and MAPK14) during oxidative stress. Plays a role in a
CC       staurosporine-induced caspase-independent apoptotic pathway by
CC       regulating the nuclear translocation of AIFM1 and ENDOG and the DNase
CC       activity associated with ENDOG. Phosphorylates STK38L on 'Thr-442' and
CC       stimulates its kinase activity. In association with STK26 negatively
CC       regulates Golgi reorientation in polarized cell migration upon RHO
CC       activation (PubMed:27807006). Regulates also cellular migration with
CC       alteration of PTPN12 activity and PXN phosphorylation: phosphorylates
CC       PTPN12 and inhibits its activity and may regulate PXN phosphorylation
CC       through PTPN12. May act as a key regulator of axon regeneration in the
CC       optic nerve and radial nerve. {ECO:0000269|PubMed:16314523,
CC       ECO:0000269|PubMed:17046825, ECO:0000269|PubMed:19604147,
CC       ECO:0000269|PubMed:19782762, ECO:0000269|PubMed:19855390,
CC       ECO:0000269|PubMed:27807006}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:15917084};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:15917084};
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000269|PubMed:15917084};
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:15917084};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=12.8 uM for manganese ions {ECO:0000269|PubMed:15917084};
CC         KM=34.9 uM for cobalt ions {ECO:0000269|PubMed:15917084};
CC         KM=22.7 uM for magnesium ions {ECO:0000269|PubMed:15917084};
CC         KM=4.1 uM for zinc ions {ECO:0000269|PubMed:15917084};
CC         Vmax=2623.1 pmol/min/mg enzyme for manganese ions
CC         {ECO:0000269|PubMed:15917084};
CC         Vmax=1746.1 pmol/min/mg enzyme for cobalt ions
CC         {ECO:0000269|PubMed:15917084};
CC         Vmax=129.1 pmol/min/mg enzyme for magnesium ions
CC         {ECO:0000269|PubMed:15917084};
CC         Vmax=22.3 pmol/min/mg enzyme for zinc ions
CC         {ECO:0000269|PubMed:15917084};
CC   -!- SUBUNIT: Monomer (PubMed:20124694). Interacts with CTTNBP2NL
CC       (PubMed:18782753). Interacts with RIPOR1 (via C-terminus); this
CC       interaction occurs in a PDCD10-dependent and Rho-independent manner
CC       (PubMed:27807006). Interacts with PDCD10; this interaction is required
CC       for the association of STK24 with RIPOR1 (PubMed:27807006).
CC       {ECO:0000269|PubMed:18782753, ECO:0000269|PubMed:20124694,
CC       ECO:0000269|PubMed:27807006}.
CC   -!- INTERACTION:
CC       Q9Y6E0; Q9P2B4: CTTNBP2NL; NbExp=5; IntAct=EBI-740175, EBI-1774273;
CC       Q9Y6E0; Q9BUL8: PDCD10; NbExp=11; IntAct=EBI-740175, EBI-740195;
CC       Q9Y6E0; Q5VSL9: STRIP1; NbExp=4; IntAct=EBI-740175, EBI-1773588;
CC       Q9Y6E0; O43815: STRN; NbExp=4; IntAct=EBI-740175, EBI-1046642;
CC       Q9Y6E0; Q9Y228: TRAF3IP3; NbExp=2; IntAct=EBI-740175, EBI-765817;
CC       Q9Y6E0-2; Q9Y376: CAB39; NbExp=3; IntAct=EBI-10299018, EBI-306905;
CC       Q9Y6E0-2; Q9BUL8: PDCD10; NbExp=9; IntAct=EBI-10299018, EBI-740195;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Membrane. Note=The truncated
CC       form (MST3/N) translocates to the nucleus. Colocalizes with STK38L in
CC       the membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=B;
CC         IsoId=Q9Y6E0-1; Sequence=Displayed;
CC       Name=A;
CC         IsoId=Q9Y6E0-2; Sequence=VSP_004874;
CC   -!- TISSUE SPECIFICITY: Isoform A is ubiquitous. Isoform B is expressed in
CC       brain with high expression in hippocampus and cerebral cortex.
CC   -!- PTM: Proteolytically processed by caspases during apoptosis.
CC       Proteolytic cleavage results in kinase activation, nuclear
CC       translocation of the truncated form (MST3/N) and the induction of
CC       apoptosis. {ECO:0000269|PubMed:12107159}.
CC   -!- PTM: Isoform B is activated by phosphorylation by PKA. Oxidative stress
CC       induces phosphorylation. Activated by autophosphorylation at Thr-190
CC       and phosphorylation at this site is essential for its function.
CC       Manganese, magnesium and cobalt-dependent autophosphorylation is mainly
CC       on threonine residues while zinc-dependent autophosphorylation is on
CC       both serine and threonine residues. {ECO:0000269|PubMed:10644707,
CC       ECO:0000269|PubMed:17046825, ECO:0000269|PubMed:19604147,
CC       ECO:0000269|PubMed:20124694}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF024636; AAB82560.1; -; mRNA.
DR   EMBL; AF083420; AAD42039.1; -; mRNA.
DR   EMBL; AL356423; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137249; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471085; EAX08986.1; -; Genomic_DNA.
DR   EMBL; BC035578; AAH35578.1; -; mRNA.
DR   CCDS; CCDS32001.1; -. [Q9Y6E0-2]
DR   CCDS; CCDS9488.1; -. [Q9Y6E0-1]
DR   RefSeq; NP_001027467.2; NM_001032296.3. [Q9Y6E0-2]
DR   RefSeq; NP_003567.2; NM_003576.4. [Q9Y6E0-1]
DR   PDB; 3A7F; X-ray; 1.55 A; A=27-315.
DR   PDB; 3A7G; X-ray; 2.00 A; A/B=27-315.
DR   PDB; 3A7H; X-ray; 1.96 A; A/B=27-315.
DR   PDB; 3A7I; X-ray; 1.45 A; A=27-315.
DR   PDB; 3A7J; X-ray; 1.50 A; A=27-315.
DR   PDB; 3CKW; X-ray; 1.96 A; A=31-323.
DR   PDB; 3CKX; X-ray; 2.70 A; A=31-323.
DR   PDB; 3ZHP; X-ray; 2.90 A; C/D=31-301.
DR   PDB; 4O27; X-ray; 3.19 A; B=30-309.
DR   PDB; 4QML; X-ray; 1.88 A; A=24-315.
DR   PDB; 4QMM; X-ray; 1.85 A; A=24-315.
DR   PDB; 4QMN; X-ray; 2.09 A; A=27-315.
DR   PDB; 4QMO; X-ray; 1.90 A; A=24-315.
DR   PDB; 4QMP; X-ray; 2.00 A; A=24-315.
DR   PDB; 4QMQ; X-ray; 1.77 A; A=24-315.
DR   PDB; 4QMS; X-ray; 1.88 A; A=24-315.
DR   PDB; 4QMT; X-ray; 1.50 A; A=24-315.
DR   PDB; 4QMU; X-ray; 1.55 A; A=24-315.
DR   PDB; 4QMV; X-ray; 2.40 A; A=24-315.
DR   PDB; 4QMW; X-ray; 1.60 A; A=24-315.
DR   PDB; 4QMX; X-ray; 1.88 A; A=24-315.
DR   PDB; 4QMY; X-ray; 1.88 A; A=24-315.
DR   PDB; 4QMZ; X-ray; 1.88 A; A=24-315.
DR   PDB; 4QNA; X-ray; 1.85 A; A=27-315.
DR   PDB; 4QO9; X-ray; 2.20 A; A/B=24-315.
DR   PDB; 4U8Z; X-ray; 1.63 A; A=24-310.
DR   PDB; 4W8D; X-ray; 1.77 A; A=24-310.
DR   PDB; 4W8E; X-ray; 1.79 A; A=24-311.
DR   PDB; 7B30; X-ray; 2.10 A; A=4-301.
DR   PDB; 7B31; X-ray; 1.80 A; A=4-301.
DR   PDB; 7B32; X-ray; 1.75 A; A=4-301.
DR   PDB; 7B33; X-ray; 1.90 A; A=4-301.
DR   PDB; 7B34; X-ray; 2.10 A; A=4-301.
DR   PDB; 7B35; X-ray; 2.40 A; A/B=4-301.
DR   PDBsum; 3A7F; -.
DR   PDBsum; 3A7G; -.
DR   PDBsum; 3A7H; -.
DR   PDBsum; 3A7I; -.
DR   PDBsum; 3A7J; -.
DR   PDBsum; 3CKW; -.
DR   PDBsum; 3CKX; -.
DR   PDBsum; 3ZHP; -.
DR   PDBsum; 4O27; -.
DR   PDBsum; 4QML; -.
DR   PDBsum; 4QMM; -.
DR   PDBsum; 4QMN; -.
DR   PDBsum; 4QMO; -.
DR   PDBsum; 4QMP; -.
DR   PDBsum; 4QMQ; -.
DR   PDBsum; 4QMS; -.
DR   PDBsum; 4QMT; -.
DR   PDBsum; 4QMU; -.
DR   PDBsum; 4QMV; -.
DR   PDBsum; 4QMW; -.
DR   PDBsum; 4QMX; -.
DR   PDBsum; 4QMY; -.
DR   PDBsum; 4QMZ; -.
DR   PDBsum; 4QNA; -.
DR   PDBsum; 4QO9; -.
DR   PDBsum; 4U8Z; -.
DR   PDBsum; 4W8D; -.
DR   PDBsum; 4W8E; -.
DR   PDBsum; 7B30; -.
DR   PDBsum; 7B31; -.
DR   PDBsum; 7B32; -.
DR   PDBsum; 7B33; -.
DR   PDBsum; 7B34; -.
DR   PDBsum; 7B35; -.
DR   AlphaFoldDB; Q9Y6E0; -.
DR   SMR; Q9Y6E0; -.
DR   BioGRID; 114011; 136.
DR   DIP; DIP-40608N; -.
DR   IntAct; Q9Y6E0; 61.
DR   MINT; Q9Y6E0; -.
DR   STRING; 9606.ENSP00000365730; -.
DR   BindingDB; Q9Y6E0; -.
DR   ChEMBL; CHEMBL5082; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9Y6E0; -.
DR   GuidetoPHARMACOLOGY; 2217; -.
DR   GlyGen; Q9Y6E0; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9Y6E0; -.
DR   MetOSite; Q9Y6E0; -.
DR   PhosphoSitePlus; Q9Y6E0; -.
DR   SwissPalm; Q9Y6E0; -.
DR   BioMuta; STK24; -.
DR   DMDM; 13626607; -.
DR   EPD; Q9Y6E0; -.
DR   jPOST; Q9Y6E0; -.
DR   MassIVE; Q9Y6E0; -.
DR   MaxQB; Q9Y6E0; -.
DR   PaxDb; Q9Y6E0; -.
DR   PeptideAtlas; Q9Y6E0; -.
DR   PRIDE; Q9Y6E0; -.
DR   ProteomicsDB; 86657; -. [Q9Y6E0-1]
DR   ProteomicsDB; 86658; -. [Q9Y6E0-2]
DR   Antibodypedia; 10785; 354 antibodies from 32 providers.
DR   DNASU; 8428; -.
DR   Ensembl; ENST00000376547.7; ENSP00000365730.3; ENSG00000102572.15. [Q9Y6E0-1]
DR   Ensembl; ENST00000539966.6; ENSP00000442539.2; ENSG00000102572.15. [Q9Y6E0-2]
DR   GeneID; 8428; -.
DR   KEGG; hsa:8428; -.
DR   MANE-Select; ENST00000539966.6; ENSP00000442539.2; NM_001032296.4; NP_001027467.2. [Q9Y6E0-2]
DR   UCSC; uc001vnm.3; human. [Q9Y6E0-1]
DR   CTD; 8428; -.
DR   DisGeNET; 8428; -.
DR   GeneCards; STK24; -.
DR   HGNC; HGNC:11403; STK24.
DR   HPA; ENSG00000102572; Low tissue specificity.
DR   MIM; 604984; gene.
DR   neXtProt; NX_Q9Y6E0; -.
DR   OpenTargets; ENSG00000102572; -.
DR   PharmGKB; PA36210; -.
DR   VEuPathDB; HostDB:ENSG00000102572; -.
DR   eggNOG; KOG0201; Eukaryota.
DR   GeneTree; ENSGT00940000153476; -.
DR   InParanoid; Q9Y6E0; -.
DR   OMA; YGCFLDG; -.
DR   OrthoDB; 967913at2759; -.
DR   PhylomeDB; Q9Y6E0; -.
DR   TreeFam; TF354217; -.
DR   PathwayCommons; Q9Y6E0; -.
DR   Reactome; R-HSA-111465; Apoptotic cleavage of cellular proteins.
DR   Reactome; R-HSA-75153; Apoptotic execution phase.
DR   SABIO-RK; Q9Y6E0; -.
DR   SignaLink; Q9Y6E0; -.
DR   SIGNOR; Q9Y6E0; -.
DR   BioGRID-ORCS; 8428; 18 hits in 1112 CRISPR screens.
DR   ChiTaRS; STK24; human.
DR   EvolutionaryTrace; Q9Y6E0; -.
DR   GeneWiki; STK24; -.
DR   GenomeRNAi; 8428; -.
DR   Pharos; Q9Y6E0; Tchem.
DR   PRO; PR:Q9Y6E0; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q9Y6E0; protein.
DR   Bgee; ENSG00000102572; Expressed in secondary oocyte and 208 other tissues.
DR   ExpressionAtlas; Q9Y6E0; baseline and differential.
DR   Genevisible; Q9Y6E0; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0009267; P:cellular response to starvation; IMP:UniProtKB.
DR   GO; GO:0097194; P:execution phase of apoptosis; IMP:UniProtKB.
DR   GO; GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0048680; P:positive regulation of axon regeneration; IEA:Ensembl.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0048679; P:regulation of axon regeneration; IMP:UniProtKB.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 1.10.12.70; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR046409; PDC10_dimerisation_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis; ATP-binding;
KW   Cytoplasm; Kinase; Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..443
FT                   /note="Serine/threonine-protein kinase 24"
FT                   /id="PRO_0000086711"
FT   CHAIN           1..325
FT                   /note="Serine/threonine-protein kinase 24 36 kDa subunit"
FT                   /id="PRO_0000413618"
FT   CHAIN           326..443
FT                   /note="Serine/threonine-protein kinase 24 12 kDa subunit"
FT                   /id="PRO_0000413619"
FT   DOMAIN          36..286
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          309..337
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           278..292
FT                   /note="Bipartite nuclear localization signal"
FT   MOTIF           335..386
FT                   /note="Nuclear export signal (NES)"
FT   ACT_SITE        156
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         42..50
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         65
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         112..114
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         161
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT   BINDING         174
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT   SITE            325..326
FT                   /note="Cleavage; by caspase-3, caspase-7 and caspase-8"
FT   MOD_RES         18
FT                   /note="Phosphothreonine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:10644707"
FT   MOD_RES         190
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:17046825,
FT                   ECO:0000269|PubMed:19604147, ECO:0000269|PubMed:20124694,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         320
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983"
FT   VAR_SEQ         1..26
FT                   /note="MDSRAQLWGLALNKRRATLPHPGGST -> MAHSPVQSGLPGMQ (in
FT                   isoform A)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9353338"
FT                   /id="VSP_004874"
FT   VARIANT         414
FT                   /note="A -> V (in dbSNP:rs55953606)"
FT                   /evidence="ECO:0000269|PubMed:10644707,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041148"
FT   VARIANT         426
FT                   /note="L -> I (in dbSNP:rs55897869)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041149"
FT   MUTAGEN         18
FT                   /note="T->A: Loss of phosphorylation by PKA."
FT                   /evidence="ECO:0000269|PubMed:10644707"
FT   MUTAGEN         65
FT                   /note="K->A: Loss of activity and autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:12107159"
FT   MUTAGEN         190
FT                   /note="T->A: Loss of activity and autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:17046825"
FT   MUTAGEN         321
FT                   /note="D->N: Loss of proteolytic cleavage by caspases."
FT                   /evidence="ECO:0000269|PubMed:12107159"
FT   STRAND          27..30
FT                   /evidence="ECO:0007829|PDB:7B32"
FT   HELIX           32..34
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   STRAND          36..44
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   STRAND          46..55
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   TURN            56..58
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   STRAND          61..68
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   TURN            69..71
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   TURN            73..75
FT                   /evidence="ECO:0007829|PDB:4QMT"
FT   HELIX           76..88
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   STRAND          97..103
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   STRAND          106..112
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   STRAND          116..118
FT                   /evidence="ECO:0007829|PDB:3A7J"
FT   HELIX           119..123
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   STRAND          124..126
FT                   /evidence="ECO:0007829|PDB:3A7H"
FT   HELIX           130..149
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   HELIX           159..161
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   STRAND          162..164
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   STRAND          166..168
FT                   /evidence="ECO:0007829|PDB:3ZHP"
FT   STRAND          170..172
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   STRAND          183..185
FT                   /evidence="ECO:0007829|PDB:4QO9"
FT   STRAND          186..188
FT                   /evidence="ECO:0007829|PDB:4QMQ"
FT   HELIX           195..197
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   HELIX           200..203
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   HELIX           211..226
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   TURN            230..233
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   HELIX           236..245
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   STRAND          253..255
FT                   /evidence="ECO:0007829|PDB:4QML"
FT   HELIX           257..266
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   HELIX           271..273
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   HELIX           277..280
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   HELIX           284..289
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   HELIX           293..296
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   HELIX           297..309
FT                   /evidence="ECO:0007829|PDB:3A7I"
FT   INIT_MET        Q9Y6E0-2:1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   MOD_RES         Q9Y6E0-2:2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   MOD_RES         Q9Y6E0-2:4
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
SQ   SEQUENCE   443 AA;  49308 MW;  4A9FF1F6B6A88A97 CRC64;
     MDSRAQLWGL ALNKRRATLP HPGGSTNLKA DPEELFTKLE KIGKGSFGEV FKGIDNRTQK
     VVAIKIIDLE EAEDEIEDIQ QEITVLSQCD SPYVTKYYGS YLKDTKLWII MEYLGGGSAL
     DLLEPGPLDE TQIATILREI LKGLDYLHSE KKIHRDIKAA NVLLSEHGEV KLADFGVAGQ
     LTDTQIKRNT FVGTPFWMAP EVIKQSAYDS KADIWSLGIT AIELARGEPP HSELHPMKVL
     FLIPKNNPPT LEGNYSKPLK EFVEACLNKE PSFRPTAKEL LKHKFILRNA KKTSYLTELI
     DRYKRWKAEQ SHDDSSSEDS DAETDGQASG GSDSGDWIFT IREKDPKNLE NGALQPSDLD
     RNKMKDIPKR PFSQCLSTII SPLFAELKEK SQACGGNLGS IEELRGAIYL AEEACPGISD
     TMVAQLVQRL QRYSLSGGGT SSH
//
